YOLFTbeta
30

Jiangsu Hualv Biological Technology Co.Ltd.

300970 · SHE · Consumer Defensive / Farm Products

12.10CNY-0.23 (-1.87%)

Price History

Full chart

Market Stats

Previous Close12.33
Open12.35
Day Range12.01 – 12.42
52-Week Range10.81 – 37.83
Volume4.86M
Market Cap2.79B
P/E (TTM)12.83
Forward P/E0.00
EPS1.36
Dividend Yield2.87%
Beta0.91
50-Day Avg18.14
200-Day Avg19.66

About

Jiangsu Chinagreen Biological Technology Group Co.,Ltd. engages in the research, development, factory cultivation, and sale of edible fungi in China. It offers Flammulina velutipes; Pleurotus eryngii, including white jade mushroom and oyster mushroom; and Maitake mushrooms. The company was founded in 2010 and is headquartered in Suqian, China.

Company Details

  • SectorConsumer Defensive
  • IndustryFarm Products
  • CEOMr. Yangchao Yu
  • Employees2.39K
  • HeadquartersNo. 88, Ludu Avenue, Suqian, China, 223700, China
  • Websitehttps://www.chinagreenbio.com

Leadership

  • Mr. Yangchao YuChairman & GM · b. 1971
  • Mr. Qian TaoCFO, Secretary & Director · b. 1986
  • Mr. Jianfeng JiangDeputy GM & Director · b. 1965
  • Mr. Feng ZhanDeputy GM & Director · b. 1985
  • Ms. Fen LiAccounting Supervisor · b. 1981

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue575.42M609.40M578.09M751.59M996.22M1.03B1.29B
Growth (%)-+5.90%-5.14%+30.01%+32.55%+3.60%+25.17%
Cost of Revenue417.25M443.13M539.60M628.94M861.52M970.61M1.08B
Gross Profit158.17M166.27M38.49M122.66M134.71M61.50M207.98M
Gross Margin27.49%27.28%6.66%16.32%13.52%5.96%16.10%
Operating Expense30.46M32.38M32.99M49.95M86.18M82.40M73.49M
Operating Income127.72M133.88M5.50M72.71M48.52M-20.90M134.50M
Operating Margin22.20%21.97%0.95%9.67%4.87%-2.02%10.41%
EBITDA231.68M221.99M105.11M181.67M168.70M134.89M335.25M
EBITDA Margin40.26%36.43%18.18%24.17%16.93%13.07%25.95%
Net Income120.67M132.50M15.50M78.25M30.35M-47.57M110.27M
Net Income Margin20.97%21.74%2.68%10.41%3.05%-4.61%8.54%
R&D7.56M8.82M8.62M14.04M16.53M14.61M17.37M
R&D as % of Total Revenue1.31%1.45%1.49%1.87%1.66%1.42%1.34%
Interest Expense38.19M6.77M3.83M2.69M8.75M11.18M15.97M
Interest Expense % of Total Revenue6.64%1.11%0.66%0.36%0.88%1.08%1.24%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.02B1.16B1.88B1.98B2.12B2.31B2.47B
Total Liabilities280.52M313.67M438.92M457.83M551.03M786.12M797.40M
Total Equity737.21M847.84M1.43B1.51B1.55B1.49B1.64B
Cash130.03M192.00M411.21M431.65M409.95M361.14M590.12M
Net Debt22.48M------

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow213.96M199.09M83.08M179.84M166.67M137.80M345.31M
Capital Expenditure98.54M190.96M204.09M407.91M224.15M268.22M123.12M
Free Cash Flow115.42M8.13M-121.01M-228.07M-57.48M-130.42M222.19M
Dividends Paid27.74M28.82M35.77M2.69M35.55M33.55M11.54M
FCF to OCF53.94%4.08%-145.65%-126.82%-34.49%-94.64%64.35%
Dividend Paid to FCF24.04%354.57%-29.56%-1.18%-61.85%-25.73%5.19%

Earnings

Report DateJun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------
EPS Actual-0.20-0.030.130.18-0.170.440.070.86-0.15-0.21-0.300.01-0.310.06-0.080.01-0.360.460.600.70-0.41
Surprise---------------------
Timing---------------------

Key Statistics & Ratios

Market Cap2.79B
Enterprise Value3.00B
Trailing P/E12.83
Forward P/E0.00
Price / Sales1.88
Price / Book1.77
EPS1.36
Book Value10.42
Revenue (TTM)1.49B
Gross Profit (TTM)323.72M
EBITDA402.92M
Profit Margin14.12%
Operating Margin-23.24%
Return on Equity14.77%
Return on Assets6.05%
Shares Outstanding159.90M
Shares Float96.38M
Beta0.91
Dividend Yield2.87%
Dividend Rate0.50
Payout Ratio36.97%

Dividends

20261×
0.50Jun 9, 2026
20241×
0.15Jun 4, 2024
20231×
0.15May 31, 2023
20211×
0.20Jul 9, 2021

Stock Splits

  • Jun 9, 20261.3:1
  • Jul 9, 20212:1